Paper16099596
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
Kim S and 19 others. Int J Radiat Oncol Biol Phys, 2005. Cited by 228 papers, by iCite.
Cite this record
ConductScience Library. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Papers, record 16099596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16099596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Stomach Neoplasms | Major topic |
| Adult | |
| Aged | |
| Antimetabolites, Antineoplastic | |
| Chemotherapy, Adjuvant | |
| Female | |
| Fluorouracil | |
| Gastrectomy | |
| Humans | |
| Leucovorin | |
| Male | |
| Middle Aged | |
| Neoplasm Recurrence, Local | |
| Prospective Studies | |
| Radiotherapy Dosage | |
| Radiotherapy, Adjuvant | |
| Survival Rate |
Source PubMed
Cited by116
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41625476 | Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/41625476 | PubMed |
| 41291615 | Comparative study of the outcomes of robotic versus laparoscopic distal gastrectomy with hand-sewn anastomosis in Billroth-I reconstruction. | BMC Surg | 2025 | https://conductscience.org/library/papers/41291615 | PubMed |
| 40402361 | Gastric Carcinoma Patients with Advanced Pathological Lymph Node Stage Benefit from Postoperative Radiotherapy: A Retrospective Analysis. | J Gastrointest Cancer | 2025 | https://conductscience.org/library/papers/40402361 | PubMed |
| 40296904 | Classical biomarkers and non-coding RNAs associated with diagnosis and treatment in gastric cancer. | Oncol Res | 2025 | https://conductscience.org/library/papers/40296904 | PubMed |
| 38259276 | Efficacy and safety of docetaxel plus S-1-based therapy in gastric cancer: a quantitative evidence synthesis of randomized controlled trials. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38259276 | PubMed |
| 37959193 | Updated Adjuvant Chemotherapy for Gastric Cancer. | J Clin Med | 2023 | https://conductscience.org/library/papers/37959193 | PubMed |
| 37433916 | Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study. | Surg Endosc | 2023 | https://conductscience.org/library/papers/37433916 | PubMed |
| 36172711 | alpha2,3 sialic acid processing enzymes expression in gastric cancer tissues reveals that ST3Gal3 but not Neu3 are associated with Lauren's classification, angiolymphatic invasion and histological grade. | Eur J Histochem | 2022 | https://conductscience.org/library/papers/36172711 | PubMed |
| 35116800 | The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China. | Transl Cancer Res | 2019 | https://conductscience.org/library/papers/35116800 | PubMed |
| 34386368 | Evaluating the benefit of adjuvant radiotherapy after extensive lymph node dissection for gastric cancer: a single-institute retrospective study. | Tzu Chi Med J | 2021 | https://conductscience.org/library/papers/34386368 | PubMed |
| 34238296 | Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression. | World J Surg Oncol | 2021 | https://conductscience.org/library/papers/34238296 | PubMed |
| 33804024 | Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33804024 | PubMed |
| 33613554 | An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer. | Front Immunol | 2020 | https://conductscience.org/library/papers/33613554 | PubMed |
| 32259036 | Prognostic factors for survival in patients with gastric cancer: Single-centre experience. | North Clin Istanb | 2020 | https://conductscience.org/library/papers/32259036 | PubMed |
| 31939629 | A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer. | Mol Med Rep | 2020 | https://conductscience.org/library/papers/31939629 | PubMed |
| 31897342 | Postoperative Radiotherapy Improves Survival in Gastric Signet-Ring Cell Carcinoma: a SEER Database Analysis. | J Gastric Cancer | 2019 | https://conductscience.org/library/papers/31897342 | PubMed |
| 31859917 | ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER? | Arq Bras Cir Dig | 2019 | https://conductscience.org/library/papers/31859917 | PubMed |
| 31702665 | Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/31702665 | PubMed |
| 31558973 | Current status of adjuvant chemotherapy for gastric cancer. | World J Gastrointest Oncol | 2019 | https://conductscience.org/library/papers/31558973 | PubMed |
| 31057329 | False discovery rate control for high dimensional networks of quantile associations conditioning on covariates. | J R Stat Soc Series B Stat Methodol | 2018 | https://conductscience.org/library/papers/31057329 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16099596
GET https://conductscience.org/api/papers/v1/16099596/cited_by?page=2